Basic Principles and Technologies for Deciphering the Genetic Map of Cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  World Journal of Surgery

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00268-008-9851-yPMID 19115029PMCID PMC2924149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BMC Genomics BioMed Central

  2009cited by this paper
• Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays

  2008cited by this paper
• XRCC2 and XRCC3 Gene Polymorphismand Risk of Pancreatic Cancer

  2008cited by this paper
• The complete genome of an individual by massively parallel DNA sequencing

  2008cited by this paper
• Research ethics and the challenge of whole-genome sequencing

  2008cited by this paper
• Oncogenes and cancer.

  2008cited by this paper
• Cancer atlas maps out sample worries

  2007cited by this paper
• Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.

  2007cited by this paper
• Faculty Opinions recommendation of A "silent" polymorphism in the MDR1 gene changes substrate specificity.

  2007cited by this paper
• Strategies for screening for pancreatic adenocarcinoma in high-risk patients.

  2007cited by this paper
• Glutathione S‐transferase gene polymorphisms and risk and survival of pancreatic cancer

  2007cited by this paper
• Mapping the cancer genome

  2007cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• The Mutant Form of Lamin A that Causes Hutchinson-Gilford Progeria Is a Biomarker of Cellular Aging in Human Skin

  2007cited by this paper
• The genomics revolution and radiotherapy.

  2007cited by this paper
• Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"

  2007cited by this paper
• A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

  2007cited by this paper
• Pancreatic Cancer Epidermal Growth Factor Receptor (EGFR) Intron 1 Polymorphism Influences Postoperative Patient Survival and in vitro Erlotinib Response

  2007cited by this paper
• Advances in counselling and surveillance of patients at risk for pancreatic cancer

  2007cited by this paper
• Characterizing the cancer genome in lung adenocarcinoma

  2007cited by this paper
• Cancer genome sequencing: the challenges ahead.

  2007cited by this paper
• Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

  2007cited by this paper
• Medicine. Reestablishing the researcher-patient compact.

  2007cited by this paper
• Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

  2007cited by this paper
• EGFR and K-ras Mutation Analysis in Non-Small Cell Lung Cancer: Comparison of Paraffin Embedded versus Frozen Specimens

  2007cited by this paper
• Tumor-stroma interactions in pancreatic ductal adenocarcinoma

  2007cited by this paper
• An overview of laser microdissection technologies.

  2007cited by this paper
• Standard operating procedure for the collection of fresh frozen tissue samples.

  2007cited by this paper
• Genome-wide in situ exon capture for selective resequencing

  2007cited by this paper
• Direct selection of human genomic loci by microarray hybridization

  2007cited by this paper
• Getting to personalized cancer medicine

  2007cited by this paper
• Effects of base excision repair gene polymorphisms on pancreatic cancer survival

  2007cited by this paper
• Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study

  2007cited by this paper
• Single nucleotide polymorphism array analysis of cancer

  2007cited by this paper
• Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians

  2007cited by this paper
• Reestablishing the Researcher-Patient Compact

  2007cited by this paper
• A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing

  2007cited by this paper
• The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.

  2007cited by this paper
• Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"

  2007cited by this paper
• Haplotype of N-Acetyltransferase 1 and 2 and Risk of Pancreatic Cancer

  2007cited by this paper
• The emergence of an ethical duty to disclose genetic research results: international perspectives

  2006cited by this paper
• Genetics. No longer de-identified.

  2006cited by this paper
• No Longer De-Identified

  2006cited by this paper
• Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1

  2006cited by this paper
• Currents in Contemporary Ethics: Meeting the Growing Demands of Genetic Research

  2006cited by this paper
• Pharmacogenetics of cancer chemotherapy.

  2006cited by this paper
• Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

  2006cited by this paper
• Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.

  2006cited by this paper
• CancerGenes: a gene selection resource for cancer genome projects

  2006cited by this paper
• Selected polymorphisms of DNA repair genes and risk of pancreatic cancer.

  2006cited by this paper
• The genetics of nicotine dependence: relationship to pancreatic cancer.

  2006cited by this paper
• Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays.

  2006cited by this paper
• Generation of mutator mutants during carcinogenesis.

  2006cited by this paper
• Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.

  2006cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis.

  2006cited by this paper
• Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism

  2006cited by this paper
• Meeting the growing demands of genetic research.

  2006cited by this paper
• Returning genetic research results to individuals: points-to-consider.

  2006cited by this paper
• Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer

  2006cited by this paper
• The New Era in Cancer Research

  2006cited by this paper
• Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses.

  2005cited by this paper
• Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways

  2005cited by this paper
• Informing research participants of research results: analysis of Canadian university based research ethics board policies

  2005cited by this paper
• An Open Letter to Cancer Researchers

  2005cited by this paper
• A genome-wide scalable SNP genotyping assay using microarray technology

  2005cited by this paper
• Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer.

  2005cited by this paper
• In vivo Therapeutic Responses Contingent on Fanconi Anemia/BRCA2 Status of the Tumor

  2005cited by this paper
• Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

  2005cited by this paper
• Specialized DNA Arrays for the Differentiation of Pancreatic Tumors

  2005cited by this paper
• Toward the 1,000 dollars human genome.

  2005cited by this paper
• Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer.

  2005cited by this paper
• Management strategies for patients with hereditary pancreatic cancer

  2005cited by this paper
• Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA.

  2005cited by this paper
• Whole-Genome Patterns of Common DNA Variation in Three Human Populations

  2005cited by this paper
• EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

  2005cited by this paper
• Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay.

  2005cited by this paper
• Genetic instability in cancer: theory and experiment.

  2005cited by this paper
• Genome sequencing in microfabricated high-density picolitre reactors

  2005cited by this paper
• Toward the $1000 human genome

  2005cited by this paper
• Searching for cancer-associated gene polymorphisms: promises and obstacles.

  2004cited by this paper
• Farnesyltransferase inhibitors.

  2004cited by this paper
• Genomic variants in exons and introns: identifying the splicing spoilers

  2004cited by this paper
• Cancer genes and the pathways they control

  2004cited by this paper
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

  2004cited by this paper
• Genetics of the FANCA gene in familial pancreatic cancer

  2004cited by this paper
• Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.

  2004cited by this paper
• Therapeutic targeting in the estrogen receptor hormonal pathway.

  2004cited by this paper
• A census of human cancer genes

  2004cited by this paper
• Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.

  2004cited by this paper
• Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material.

  2004cited by this paper
• Solexa Ltd.

  2004cited by this paper
• Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

  2003cited by this paper
• High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism.

  2003cited by this paper
• Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

  2003cited by this paper
• Highly parallel SNP genotyping.

  2003cited by this paper
• Abnormalities of tumor suppressor gene p16in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters

  2003cited by this paper
• Functional analysis of human promoter polymorphisms.

  2003cited by this paper
• Welcome to the genomic era.

  2003cited by this paper
• Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K‐ras activation in human exocrine pancreatic cancer

  2003cited by this paper

• Strategies for modern biomarker and drug development in oncology

  2014cites this paper
• Genomic sequencing of key genes in mouse pancreatic cancer cells.

  2012cites this paper
• Paired Tumor and Normal Whole Genome Sequencing of Metastatic Olfactory Neuroblastoma

  2012cites this paper
• Cancer genomics: technology, discovery, and translation.

  2012cites this paper
• Overview of the Development of Personalized Genomic Medicine and Surgery

  2011cites this paper
• A Primer on a Hepatocellular Carcinoma Bioresource Bank Using the Cancer Genome Atlas Guidelines: Practical Issues and Pitfalls

  2011cites this paper
• Building a Comprehensive Genomic Program for Hepatocellular Carcinoma

  2011cites this paper
• Genetic Variation and its Role in Malignancy

  2011cites this paper
• Defining the Cancer Master Switch

  2011cites this paper
• Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study

  2010cites this paper
• Single nucleotide polymorphism in RECQL and survival in resectable pancreatic adenocarcinoma.

  2009cites this paper